I came across the following post in another peptide group this morning. I'm reposting it exactly as it appeared: "H3H Happenings H3H Situation: NOT good. First raws were hard to get, then good raws were hard to get and now china has cracked down even harder on not allowing the sale or production of H3h. I truly cannot tell you if this is a permanent thing or how long this will be, but from what sources are saying it won’t be anytime soon. They, much like I, face imprisonment of loosing everything for merely stocking one item so most aren’t even risking it. They now have to hold a special license in order to purchase raws. With that being said I’ve done a hard inventory of what I have left. There’s no more ordered, no more in route, no hidden stash, and it will not ever be restocked. Less than 50 kits left of 24iu and 36iu and they’re currently listed under a24iu or a36iu. Once you see that sold out button—that’s it. This is such a good one, does so much good, but they’re yanking it out from under us. I even want to panic hoard and I have been. Even more so now." SO I WENT LOOKING. There is some truth behind what is being reported, but there are also some conclusions being drawn that I cannot currently validate. China does tightly regulate HGH and other peptide hormones. Growth Hormone (GH) is specifically included in China's 2026 prohibited-substances catalog, and production, sale, import and export of these substances are controlled. China also requires licensing and regulatory approval for legitimate manufacture and wholesale handling of peptide hormones. But from what I've read and can find that licensing requirement isn't new. What is important is that China introduced revised Drug Administration regulations in May 2026 and has been tightening manufacturing oversight, licensing, GMP compliance and traceability. So, it is certainly possible that manufacturers operating outside the legitimate pharmaceutical system are deciding that producing or handling HGH is no longer worth the regulatory risk.